Evidence map›Paper›PMID 36651980›Full record

ArticleAnnals of hematology2023

Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia.

Martin Stanulla, Denis M Schewe, Beat Bornhauser, Jean-Pierre Bourquin, Cornelia Eckert, Wolfgang Eberl, Saskia Wolf, Julian Wolf, Fotini Vogiatzi, Anke K Bergmann and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Martin StanullaDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625, Hannover, Germany. stanulla.martin@mh-hannover.de.ORCID 0000-0002-3834-0727
Denis M ScheweDepartment of Pediatrics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Beat BornhauserDivision of Pediatric Oncology, and Children Research Center, University Children's Hospital, Zurich, Switzerland.
Jean-Pierre BourquinDivision of Pediatric Oncology, and Children Research Center, University Children's Hospital, Zurich, Switzerland.
Cornelia EckertCharité, University Hospital Berlin, Pediatric Hematology/Oncology, Berlin, Germany.
Wolfgang EberlCenter for Child and Adolescent Medicine, Department of Hematology and Oncology, Städtisches Klinikum Braunschweig gGmbH, Braunschweig, Germany.
Saskia WolfDepartment of Pediatrics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Julian WolfDepartment of Pediatrics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Fotini VogiatziPediatric Hematology/Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Anke K BergmannInstitute of Human Genetics, Hannover Medical School, Hannover, Germany.
Gunnar CarioPediatric Hematology/Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Rita BeierDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625, Hannover, Germany.
Martin SauerDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625, Hannover, Germany.
Christian P KratzDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625, Hannover, Germany.
Britta Maecker-KolhoffDepartment of Pediatric Hematology and Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625, Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteAntibodies, MonoclonalAntineoplastic Combined Chemotherapy ProtocolsBridged Bicyclo Compounds, HeterocyclicHumansPhenotypeSulfonamidesAntibodies, MonoclonalBridged Bicyclo Compounds, HeterocyclicdaratumumabSulfonamidesvenetoclaxAcute lymphoblastic leukemiaDaratumumabMixed phenotype acute leukemiaVenetoclax

Identifiers

PMID36651980
PMCPMC9977701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.